Pfizer (PFE) Announces FDA Acceptance for Priority Review of sBLA for 20vPnC

Go back to Pfizer (PFE) Announces FDA Acceptance for Priority Review of sBLA for 20vPnC
Pfizer Inc. (NYSE: PFE) Delayed: 27.53 -0.11 (0.4%)
Previous Close $27.64    52 Week High $37.39 
Open $27.64    52 Week Low $28.25 
Day High $27.66    P/E 16.68 
Day Low $27.34    EPS $1.65 
Volume 14,454,334